Current Issue


Intensive therapy to lower HbA1c, BP, and cholesterol failed to reduce mortality

The trial included 2,542 patients ages 45 to 69 years who had type 2 diabetes with an HbA1c of 6.9% or higher and hypertension, dyslipidemia, or both, recruited at 81 sites in Japan.

Diabetes associated with fractures in older male veterans, with comorbidities as mediating factors

The retrospective study involved nearly 2.8 million male veterans 65 to 99 years of age, 32.3% with diabetes, who received primary care at Veterans Health Administration medical centers from 2000 to 2010.

Rates of diabetes-related ESRD appear to decrease in U.S., Puerto Rico

From 2000 to 2014, the age-standardized incidence of end-stage renal disease (ESRD) attributed to diabetes decreased from 260.2 to 173.9 per 100,000 diabetic population.

MKSAP quiz: Elevated HbA1c in type 1 diabetes

This month's quiz asks readers to determine the appropriate management of an elevated HbA1c level in a 27-year-old woman with type 1 diabetes.

VA and DoD offer guideline on managing type 2 diabetes with summary in Annals

The summary describes ways in which the Veterans Affairs/Department of Defense (VA/DoD) guideline differs from recommendations from the American Diabetes Association, the American Geriatrics Society, and the American Association of Clinical Endocrinologists.

Undiagnosed diabetes may be less common in U.S. than previously estimated

The overall prevalence of diabetes (diagnosed and confirmed undiagnosed) increased from 5.5% of the U.S. population in 1988 to 1994 to 10.8% in 2011 to 2014, according to data from the National Health and Nutrition Examination Survey (NHANES).

Self-monitoring of blood glucose did not improve HbA1c or QOL at 1 year in non-insulin-treated type 2 diabetes

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according to an ACP Journal Club commentary.

Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death

The review suggests that treating diabetes with strict glycemic control does not reduce mortality or cardiovascular risk or slow progression of kidney disease, and the results question whether strict glycemic control for preventing any complications is warranted, ACP Journal Club authors wrote.

ACP updates “Living with Diabetes” patient guidebook

An award-winning guidebook helps patients learn about diet, exercise, blood glucose monitoring, the importance of foot exams, and management of insulin and other medicines.